Ambroxol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells

Archives of Pharmacal Research

Volumn 37, Issue 4, 2014, Pages 520-529

  Yamaya, Mutsuo ^a   Nishimura, Hidekazu ^b   Nadine, Lusamba Kalonji ^a   Ota, Chiharu ^a   Kubo, Hiroshi ^a   Nagatomi, Ryoichi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SENDAI CITY MEDICAL CENTER   (Japan)

Author keywords

Airway epithelium; Ambroxol; Infection control; Inflammation; Intercellular adhesion molecule 1 (ICAM 1); Rhinovirus

Indexed keywords

AMBROXOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; VIRUS RNA; ANTIVIRUS AGENT; CYTOKINE;

AGED; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BLOOD LEVEL; DRUG EFFECT; ENDOSOME; EPITHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN RHINOVIRUS B14; INFECTION SENSITIVITY; MALE; PRIMARY CULTURE; PROTEIN EXPRESSION; RHINOVIRUS INFECTION; SUPERNATANT; TRACHEA; TRACHEAL EPITHELIAL CELL; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TITRATION; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PICORNAVIRIDAE INFECTIONS; PRIMARY CELL CULTURE; RHINOVIRUS; VIROLOGY;

AMBROXOL; ANTIVIRAL AGENTS; CELLS, CULTURED; CYTOKINES; ENDOSOMES; EPITHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NF-KAPPA B; PICORNAVIRIDAE INFECTIONS; PRIMARY CELL CULTURE; RHINOVIRUS; RNA, VIRAL; TRACHEA;

EID: 84897546091     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0210-7     Document Type: Article

References (41)

1. Akira, S.; T. Hirano, T. Taga, and T. Kishimoto. 1990. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). The FASEB Journal 4: 2860-2867.
2. Blesa, S.; J. Cortijo, M. Mata, A. Serrano, D. Closa, F. Santangelo, J.M. Estrela, J. Suchankova, and E.J. Morcillo. 2003. Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen. European Respiratory Journal 21: 394-400.
3. Casasnovas, J.M.; and T.A. Springer. 1994. Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): An intermediate in which ICAM-1 is bound and RNA is released. Journal of Virology 68: 5882-5889.
4. Condit, R.C. 2006. Principles of virology. In Fields virology, 5th ed, ed. D.M. Knipe, and P.M. Howley, 25-57. Philadelphia: Lippincott Williams and Wilkins.
5. + secretion by cortical distal tubule. Journal of Membrane Biology 157: 193-201.
6. Gibbs, B.F.; W. Schmutzler, I.B. Vollrath, P. Brosthardt, U. Braam, H.H. Wolff, and G. Zwadlo-Klarwasser. 1999. Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells. Inflammation Research 48: 86-93.
7. Greve, J.M.; G. Davis, A.M. Meyer, C.P. Forte, S.C. Yost, C.W. Marlor, M.E. Kamarck, and A. McClelland. 1989. The major human rhinovirus receptor is ICAM-1. Cell 56: 839-847.
8. Hasegawa, I.; N. Niisato, Y. Iwasaki, and Y. Marunaka. 2006. Ambroxol-induced modification of ion transport in human airway Calu-3 epithelia. Biochemical and Biophysical Research Communications 343: 475-482.
9. Hong, J.S.; H.H. Ko, E.S. Han, and C.S. Lee. 2003. Inhibition of bleomycin-induced cell death in rat alveolar macrophages and human lung epithelial cells by ambroxol. Biochemical Pharmacology 66: 1297-1306.
10. Jang, Y.Y.; J.H. Song, Y.K. Shin, E.S. Han, and C.S. Lee. 2003. Depressant effects of ambroxol and erdosteine on cytokine synthesis, granule enzyme release, and free radical production in rat alveolar macrophages activated by lipopolysaccharide. Pharmacology and Toxicology 92: 173-179.
11. Malerba, M.; A. Ponticiello, A. Radaeli, G. Bensi, and V. Grassi. 2004. Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial). Pulmonary Pharmacology & Therapeutics 17: 27-34.
12. Marshansky, V.; and P. Vinay. 1996. Proton gradient formation in early endosomes from proximal tubes. Biochimica et Biophysica Acta 1284: 171-180.
13. Mellman, I.; R. Fuchs, and A. Helenius. 1986. Acidification of the endocytic and exocytic pathways. Annual Review of Biochemistry 55: 663-700.
14. Mezzetti, M.; L. Colombo, M.G. Marini, V. Crusi, P. Pierfederici, and E. Mussini. 1990. A pharmacokinetic study on pulmonary tropism of ambroxol in patients under thoracic surgery. The European Journal of Emergency Surgery and Intensive Care 13: 179-185.
15. +-ATPase without ultrastructural changes in kidneys of Dent's disease patients. Kidney International 63: 1285-1295.
16. + exchanger in a late endosomal compartment of yeast. Implications for vacuole biogenesis. Journal of Biological Chemistry 273: 21054-21060.
17. Natajaran, K.; S. Singh, T.R. Burke Jr, D. Grunberger, and B.B. Aggarwal. 1996. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proceedings of the National Academy of Sciences of the United States of America 93: 9090-9095.
18. Nobata, K.; M. Fujimura, Y. Ishiura, S. Myou, and S. Nakao. 2006. Ambroxol for the prevention of acute upper respiratory disease. Clinical and Experimental Medicine 6: 79-83.
19. Nolan, T.; R.E. Hands, and S.A. Bustin. 2006. Quantification of mRNA using real-time RT-PCR. Nature Protocols 1: 1559-1582.
20. Numazaki, Y.; T. Oshima, A. Ohmi, A. Tanaka, Y. Oizumi, S. Komatsu, T. Takagi, M. Karahashi, and N. Ishida. 1987. A microplate methods for isolation of viruses from infants and children with acute respiratory infections. Microbiology and Immunology 31: 1085-1095.
21. Olivieri, D.; G. Zavatti, G. Tomasini, S. Daniotti, G. Bonsignore, G. Ferrara, N. Carnimero, R. Chianese, E. Catena, S. Marcatili, M. Del Donno, C. Grassi, E. Pozzi, V. Grassi, C. Tantucci, M. Lucchesi, G. Schimid, C.F. Marchioni, S. Penitenti, A. Mistretta, N. Crimi, L. Casali, R. Cabiddu, C. Donner, A. Patessio, V. Massei, C.M. Sanguinetti, O. Orlandi, S. Bruna, C. Serra, and A. Giacopelli. 1987. Ambroxol for the prevention of chronic bronchitis: Exacerbations: Long-term multicenter trial. Respiration 51: 42-51.
22. Papi, A.; and S.L. Johnston. 1999. Respiratory epithelial cell expression of vascular cell adhesion molecule-1 and its up-regulation by rhinovirus infection via NF-κB and GATA transcription factors. Journal of Biological Chemistry 274: 30041-30051.
23. Pérez, L.; and L. Carrasco. 1993. Entry of poliovirus into cells does not require a low-pH step. Journal of Virology 67: 4543-4548.
24. Seemungal, T.; R. Harper-Owen, A. Bhowmik, D.J. Jeffries, and J.A. Wedzicha. 2000. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. European Respiratory Journal 16: 677-683.
25. Seemungal, T.; R. Harper-Owen, A. Bhowmik, I. Moric, G. Sanderson, S. Message, P. Maccallum, T.W. Meade, D.J. Jeffries, S.L. Johnston, and J.A. Wedzicha. 2001. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 164: 1618-1623.
26. Sethi, S. 2004. New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease. Current Opinion in Infectious Diseases 17: 113-119.
27. Severina, I.S.; O.G. Bussygina, N.V. Pyatakova, Y.V. Khropov, and R.A. Krasnoperov. 2000. Ambroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclase. European Journal of Pharmacology 407: 61-64.
28. Su, F.; F. Wang, W. Gao, and H. Li. 2007. Determination of ambroxol in human plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI). Journal of Chromatography B 853: 364-368.
29. Su, X.; L. Wang, Y. Song, and C. Bai. 2004. Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide. Intensive Care Medicine 30: 133-140.
30. Subauste, M.C.; D.B. Jacoby, S.M. Richards, and D. Proud. 1995. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. Journal of Clinical Investigation 96: 549-557.
31. 1 inhibits rhinovirus infection in human airway epithelium: effects on endosome and ICAM-1. American Journal of Physiology 280: L1115-L1127.
32. Suzuki, T.; M. Yamaya, K. Sekizawa, M. Hosoda, N. Yamada, S. Ishizuka, A. Yoshino, H. Yasuda, H. Takahashi, H. Nishimura, and H. Sasaki. 2002. Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells. American Journal of Respiratory and Critical Care Medicine 165: 1113-1118.
33. Suzuki, T.; M. Yamaya, K. Sekizawa, N. Yamada, K. Nakayama, S. Ishizuka, M. Kamanaka, T. Morimoto, Y. Numazaki, and H. Sasaki. 2000. Effects of dexamethasone on rhinovirus infection in cultured human tracheal epithelial cells. American Journal of Physiology 278: L560-L571.
34. Teramoto, S.; M. Suzuki, E. Ohga, H. Ishii, T. Matsuse, and Y. Ouchi. 1999. Effects of ambroxol on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary diseases. Pharmacology 59: 135-141.
35. Turner, R.B.; and R.B. Couch. 2006. Rhinoviruses. In Fields Virology, 5th ed, ed. D.M. Knipe, and P.M. Howley, 895-909. Philadelphia: Lippincott Williams and Wilkins.
36. van de Stolpe, A.; and P.T. van der Saag. 1996. Intercellular adhesion molecule-1. Journal of Molecular Medicine 74: 13-33.
37. Yamaya, M.; H. Nishimura, Y. Hatachi, H. Yasuda, X. Deng, T. Sasaki, H. Kubo, and R. Nagatomi. 2012. Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells. European Respiratory Journal 40: 122-132.
38. Yamaya, M.; H. Nishimura, Y. Hatachi, M. Yoshida, H. Fujiwara, M. Asada, K. Nakayama, H. Yasuda, X. Deng, T. Sasaki, H. Kubo, and R. Nagatomi. 2011. Procaterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. European Journal of Pharmacology 650: 431-444.
39. Yang, B.; D.F. Yao, M. Ohuchi, M. Ide, M. Yano, Y. Okumura, and H. Kido. 2002. Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels. European Respiratory Journal 19: 952-958.
40. Yasuda, H.; M. Yamaya, T. Sasaki, D. Inoue, K. Nakayama, M. Yamada, M. Asada, M. Yoshida, T. Suzuki, H. Nishimura, and H. Sasaki. 2006. Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells. European Respiratory Journal 28: 51-58.
41. Zhu, Z.; W. Tang, A. Ray, Y. Wu, O. Einarsson, M.L. Landry, J. Gwaltney Jr, and J.A. Elias. 1996. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor κB-dependent transcriptional activation. Journal of Clinical Investigation 97: 421-430.